- Patients
- Patient resources
- Jeff stelling football march
GenesisCare sponsorship supporting Prostate Cancer UK
1 in 8 men are affected by prostate cancer in the UK. Together we’re promoting the importance of early diagnosis, access to advanced treatments such as radiotherapy, and better life outcomes.
Raising awareness of an early diagnosis
As a specialist cancer care provider with 14 treatment centres throughout the UK we’re proud to be sponsoring Jeff Stelling's Football March organised by Prostate Cancer UK. We’re experts in prostate cancer care, so we know it’s vital for men who have any concerns checked, as early diagnosis leads to more treatment options and better outcomes.
Support Jeff Stelling's Football March
and help raise funds for research to save men's lives. Make a donation to Prostate Cancer UK
GenesisCare play a key role in prostate cancer care for men in the UK, we hope this is just the start of a long-term partnership with them.
Laura Kerby, Prostate Cancer UK Chief Executive
Knowing your prostate cancer risk
Prostate cancer signs and symptoms
Most men with early prostate cancer don't have any signs or symptoms. Prostate issues may include:
Difficulty starting urination
Difficulty starting urination
Finding it difficulty to start urination
Difficulty emptying your bladder
Difficulty emptying your bladder
Finding it hard to fully empty your bladder or feeling like your bladder hasn’t emptied properly
Weak urine flow
Weak urine flow
You have a weak urine flow
Urinating more often, particularly at night
Urinating more often, particularly at night
Needing to urinate more often, particularly during the night
Some factors may increase the risk of prostate cancer, including:
Age
Age
Most cases are diagnosed in men over 50.
Family history
Family history
If you have a family history of prostate cancer.
Ethnicity
Ethnicity
Black men are at significantly higher risk. 1 in 4 black men get prostate cancer compared to 1 in 8 overall.
Learn about prostate cancer causes, risk factors and symptoms
I encourage men concerned about prostate cancer to speak to their GP, as the earlier it's diagnosed, the more treatment options you have
Amardeep, GenesisCare patient
Five-day radiotheraphy for prostate cancer
Recent advances in radiotherapy technology means patients with prostate cancer can now be treated in as little as five days over the course of one week, instead of the standard 20-39 radiotherapy sessions over many weeks.
Patients having their prostate cancer treatment over a shorter period, can return to their day-to-day life much quicker.
My prostate cancer was fully treated in just 5 days at GenesisCare, with radiotherapy on the innovative MRIdian and I went straight back to normal life.
Geoff, GenesisCare patient
We're working with Prostate Cancer UK to encourage men to be vigilant and take charge of their health today, for a healthier tomorrow
Justin Hely, General Manager GenesisCare UK
About GenesisCare
We’re the UK’s leading independent specialist cancer care provider, transforming cancer care with advanced diagnostics, medical oncology, radiotherapy and theranostics, to achieve the best possible life outcomes for our patients.
Operating 14 specialist outpatient centres, our world-class standard of care gives access to the latest innovative treatments proven to be safe and effective, delivered by our highly trained physicians and healthcare professionals.
We specialise in the latest techniques for diagnosing and treating prostate cancer and our teams of expert uro-oncologists continually evaluate the latest prostate cancer treatments so we can offer the most up-to-date options to every patient without delay.
Make an enquiry
If you have any concerns about prostate cancer, please contact our team today.
Our CQC rating
We’re registered with the CQC who inspect and monitor healthcare services in England and make sure they’re safe, effective, caring, responsive and well-led. The CQC has rated 13 of our 14 centres as outstanding or good, with the remaining centre awaiting inspection. We also review our own centres regularly and receive patient feedback scores for our high-quality care. During 2022, 92% of our patients would recommend us to friends and family.